{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:32:27Z","timestamp":1720654347642},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBM"],"DOI":"10.2147\/jbm.s36249","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T23:27:50Z","timestamp":1460503670000},"page":"39","source":"Crossref","is-referenced-by-count":3,"title":["Critical appraisal of eculizumab for atypical hemolytic uremic syndrome"],"prefix":"10.2147","author":[{"given":"Craig","family":"Langman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,4]]},"container-title":["Journal of Blood Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=29844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:40:39Z","timestamp":1477867239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/critical-appraisal-of-eculizumab-for-atypical-hemolytic-uremic-syndrom-peer-reviewed-article-JBM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/jbm.s36249","relation":{},"ISSN":["1179-2736"],"issn-type":[{"value":"1179-2736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}